Boxer Capital, LLC Protara Therapeutics, Inc. Transaction History
Boxer Capital, LLC
- $1.8 Billion
- Q2 2024
A detailed history of Boxer Capital, LLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Boxer Capital, LLC holds 811,627 shares of TARA stock, worth $1.53 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
811,627
Previous 209,227
287.92%
Holding current value
$1.53 Million
Previous $839,000
101.19%
% of portfolio
0.09%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding TARA
# of Institutions
43Shares Held
10.4MCall Options Held
25KPut Options Held
12.7K-
Opaleye Management Inc. Boston, MA2.3MShares$4.36 Million1.23% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.9MShares$3.59 Million0.06% of portfolio
-
Stem Point Capital LP New York, NY984KShares$1.86 Million0.6% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il665KShares$1.26 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY537KShares$1.01 Million0.01% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $21.3M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...